- Home
- PSTL vs JUNS Comparison
PSTL vs JUNS Comparison
Compare PSTL & JUNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSTL
- JUNS
- Stock Information
- Founded
- PSTL 2018
- JUNS 2015
- Country
- PSTL United States
- JUNS United States
- Employees
- PSTL N/A
- JUNS N/A
- Industry
- PSTL Real Estate Investment Trusts
- JUNS
- Sector
- PSTL Real Estate
- JUNS
- Exchange
- PSTL Nasdaq
- JUNS NYSE
- Market Cap
- PSTL 306.4M
- JUNS 281.4M
- IPO Year
- PSTL 2019
- JUNS 2024
- Fundamental
- Price
- PSTL $13.18
- JUNS $5.42
- Analyst Decision
- PSTL Strong Buy
- JUNS
- Analyst Count
- PSTL 1
- JUNS 0
- Target Price
- PSTL $15.50
- JUNS N/A
- AVG Volume (30 Days)
- PSTL 167.5K
- JUNS 494.3K
- Earning Date
- PSTL 02-24-2025
- JUNS 02-11-2025
- Dividend Yield
- PSTL 7.35%
- JUNS N/A
- EPS Growth
- PSTL N/A
- JUNS N/A
- EPS
- PSTL 0.08
- JUNS N/A
- Revenue
- PSTL $72,005,000.00
- JUNS N/A
- Revenue This Year
- PSTL N/A
- JUNS N/A
- Revenue Next Year
- PSTL $10.45
- JUNS N/A
- P/E Ratio
- PSTL $164.49
- JUNS N/A
- Revenue Growth
- PSTL 16.87
- JUNS N/A
- 52 Week Low
- PSTL $12.43
- JUNS $3.86
- 52 Week High
- PSTL $15.15
- JUNS $19.51
- Technical
- Relative Strength Index (RSI)
- PSTL 51.68
- JUNS N/A
- Support Level
- PSTL $12.43
- JUNS N/A
- Resistance Level
- PSTL $13.11
- JUNS N/A
- Average True Range (ATR)
- PSTL 0.22
- JUNS 0.00
- MACD
- PSTL 0.08
- JUNS 0.00
- Stochastic Oscillator
- PSTL 100.00
- JUNS 0.00
About PSTL Postal Realty Trust Inc.
Postal Realty Trust Inc is an internally managed real estate corporation that owns and manages properties leased to the United States Postal Service, or the USPS. Its objective is to create stockholder value by generating risk-adjusted returns through expanding its portfolio of owned and managed postal properties leased to the USPS. The majority of the revenue is generated from the rental income received.
About JUNS JUPITER NEUROSCIENCES INC
Jupiter Neurosciences Inc is a clinical stage research and development pharmaceutical company located in Jupiter, Florida. The company has developed a unique resveratrol platform product primarily targeting treatment of neuro-inflammation. Its platform product, JOTROL, offers potential therapeutic benefit to most central nervous system diseases such as Alzheimer's disease, ataxias, and metabolic disorders such as Lysosomal Storage Disorders and mitochondrial diseases.